Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis
Wenlong Liu(Guangzhou Medical University), Renzhong Luo(Guangzhou Medical University), Rongshan Chen(Beihang University), Chun-Hui He(Guangzhou Women and Children Medical Center), Shengbao Yan(Guangzhou Medical University), Xi Luo(Taizhou University), Qingxiang Zeng(Guangzhou Medical University), Yiquan Tang(Guangzhou Medical University)
Cited by 57
Related Papers
Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy
|Journal of Allergy and Clinical Immunology|2012|304
Mitochondrial Dysfunction in Neural Injury
|Frontiers in Neuroscience|2019|124
Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: A multi-center study
|PLoS ONE|2021|68
Spectrum and Clinical Characteristics of Symptomatic and Asymptomatic Coronavirus Disease 2019 (COVID-19) With and Without Pneumonia
|Frontiers in Medicine|2021|63
MicroRNA‐181a and microRNA‐155 are involved in the regulation of the differentiation and function of regulatory T cells in allergic rhinitis children
|Pediatric Allergy and Immunology|2019|49